EVOLET offers out-licensing opportunities for selected pharmaceutical products, granting qualified partners exclusive or non-exclusive rights to register, market, and distribute products within defined territories.

Partners receive comprehensive technical and regulatory support, including CTD/eCTD dossiers, stability data, product specifications, and registration documentation. Products are manufactured at EVOLET’s WHO-GMP-certified facilities, designed and operated in alignment with PIC/S GMP principles and applicable international quality standards, ensuring consistent quality and reliable commercial supply.

This model enables partners to accelerate market entry, reduce development risk, and focus on registration, marketing, and distribution while benefiting from EVOLET’s formulation, regulatory, and manufacturing capabilities.